216 related articles for article (PubMed ID: 10203367)
1. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
[TBL] [Abstract][Full Text] [Related]
2. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
4. Carbonyl stress in the pathogenesis of diabetic nephropathy.
Suzuki D; Miyata T
Intern Med; 1999 Apr; 38(4):309-14. PubMed ID: 10361902
[TBL] [Abstract][Full Text] [Related]
5. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
[TBL] [Abstract][Full Text] [Related]
6. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids.
Miyata T; Inagi R; Asahi K; Yamada Y; Horie K; Sakai H; Uchida K; Kurokawa K
FEBS Lett; 1998 Oct; 437(1-2):24-8. PubMed ID: 9804165
[TBL] [Abstract][Full Text] [Related]
7. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
8. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Nangaku M; Miyata T; Sada T; Mizuno M; Inagi R; Ueda Y; Ishikawa N; Yuzawa H; Koike H; van Ypersele de Strihou C; Kurokawa K
J Am Soc Nephrol; 2003 May; 14(5):1212-22. PubMed ID: 12707391
[TBL] [Abstract][Full Text] [Related]
9. N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
Schwedler SB; Verbeke P; Bakala H; Weiss MF; Vilar J; Depreux P; Fourmaintraux E; Striker LJ; Striker GE
Diabetes Obes Metab; 2001 Aug; 3(4):230-9. PubMed ID: 11520302
[TBL] [Abstract][Full Text] [Related]
10. Oxidative protein damage with carbohydrates and lipids in uremia: 'Carbonyl stress'.
Inagi R; Miyata T
Blood Purif; 1999; 17(2-3):95-8. PubMed ID: 10449866
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
12. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR
Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end-products in diabetic nephropathy.
Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
[TBL] [Abstract][Full Text] [Related]
14. N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress.
Nerlich AG; Schleicher ED
Atherosclerosis; 1999 May; 144(1):41-7. PubMed ID: 10381276
[TBL] [Abstract][Full Text] [Related]
15. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.
Suzuki D; Miyata T; Nangaku M; Takano H; Saotome N; Toyoda M; Mori Y; Zhang SY; Inagi R; Endoh M; Kurokawa K; Sakai H
J Am Soc Nephrol; 1999 Dec; 10(12):2606-13. PubMed ID: 10589701
[TBL] [Abstract][Full Text] [Related]
16. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
17. 'Carbonyl stress' and dialysis-related amyloidosis.
Miyata T; Ueda Y; Saito A; Kurokawa K
Nephrol Dial Transplant; 2000; 15 Suppl 1():25-8. PubMed ID: 10737163
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
[TBL] [Abstract][Full Text] [Related]
19. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.
Uesugi N; Sakata N; Nangaku M; Abe M; Horiuchi S; Hisano S; Iwasaki H
Am J Kidney Dis; 2004 Aug; 44(2):224-38. PubMed ID: 15264180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
